Virus Inactivation in the 1990's ? and into the 21st Century. Part 1: Skin, Bone, and Cells

by Gail Sofer, BioReliance Viruses present dangers (and therefore challenges) to biopharmaceutical manufacturing processes. The virus inactivation method chosen depends on the virus and its surrounding medium. This survey article, organized by sample type, lists viral inactivation methods published during the past decade. Part 1 presents data for skin and bone and for cells that are not platelets or blood cells.

Related Content:

Facilitating Client Audits: The Contract Laboratory Perspective

Outsourcing Outlook: Optimizing Cross-Organizational Team Performance and Management

Analytical Advances: When an Industry Requires Multiterabyte Data Protection